RECEPTKINE Trademark

Trademark Overview


On Thursday, January 12, 2023, a trademark application was filed for RECEPTKINE with the United States Patent and Trademark Office. The USPTO has given the RECEPTKINE trademark a serial number of 79362319. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 20, 2024. This trademark is owned by ILDONG PHARMACEUTICAL CO., LTD.. The RECEPTKINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for immunity adjustment; Antibodies for veterinary purposes; Chemico-pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Albuminous preparations for medical purposes; Drugs for medical purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Colostral antibodies for medical purposes; Antibody reagents for medical purposes for use in the treatment of cancer; Blood for medical purposes; Enzymes for medical purposes; Pharmaceutical drugs for use in the treatment of cancer, immune system related diseases and disorders; Human immune globulin; Medicines for human purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Human plasma protein being blood plasma; Pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Haematogen, namely, blood substitutes for human use; Pha...

Laboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines; Consultancy in the field of biotechnology; Research and development of technology for biotechnology; Scientific research in the field of biomedicine; Biological research; Biochemical research; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Drug discovery services; Development of pharmaceutical preparations and medicines; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Scientific research in the field of pharmacy; Scientific research in the field of genetic engineering; Medicine research; Laboratory research services relating to pharmaceuticals; Medical and pharmacological research services; Medical research; Medical and pharmacological research, namely, clinical trials for others; Blood analysis services for scientific research purposes; Chemical engineer...
receptkine

General Information


Serial Number79362319
Word MarkRECEPTKINE
Filing DateThursday, January 12, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for immunity adjustment; Antibodies for veterinary purposes; Chemico-pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Albuminous preparations for medical purposes; Drugs for medical purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Colostral antibodies for medical purposes; Antibody reagents for medical purposes for use in the treatment of cancer; Blood for medical purposes; Enzymes for medical purposes; Pharmaceutical drugs for use in the treatment of cancer, immune system related diseases and disorders; Human immune globulin; Medicines for human purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Human plasma protein being blood plasma; Pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Haematogen, namely, blood substitutes for human use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antivirals; Antigens for use in the treatment of cancer; Antibody reagents used for the detection of the antigens in cells and tissue for medical purposes; Pharmaceutical preparations for use in hematology
Goods and ServicesLaboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines; Consultancy in the field of biotechnology; Research and development of technology for biotechnology; Scientific research in the field of biomedicine; Biological research; Biochemical research; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Drug discovery services; Development of pharmaceutical preparations and medicines; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Scientific research in the field of pharmacy; Scientific research in the field of genetic engineering; Medicine research; Laboratory research services relating to pharmaceuticals; Medical and pharmacological research services; Medical research; Medical and pharmacological research, namely, clinical trials for others; Blood analysis services for scientific research purposes; Chemical engineering

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, February 11, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameILDONG PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameILDONG PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024NOTIFICATION PROCESSED BY IB
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, January 14, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, January 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, January 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, January 14, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, January 14, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 13, 2023REFUSAL PROCESSED BY IB
Tuesday, October 24, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 24, 2023REFUSAL PROCESSED BY MPU
Thursday, October 12, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 10, 2023ASSIGNED TO EXAMINER
Wednesday, February 15, 2023APPLICATION FILING RECEIPT MAILED
Saturday, February 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 9, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB